GHK-Cu (Copper Peptide) Dosage Guide
Complete guide to GHK-Cu (Copper Peptide) dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
1 mg – 2 mg
Frequency
Once per day
Route
subcutaneous
Cycle Length
4–8 weeks
Reconstitution
Vial Size
50 mg
BAC Water
5.0 ml
Concentration
10,000 mcg/ml
Detailed Dosage Information
Topical
Applied as serum or cream 1-2 times daily.
Injectable
1-2mg daily for research purposes.
Microneedling protocols often use 0.5-1%.
Administration Method
Most commonly used topically for skin applications. Can be injected subcutaneously for systemic effects. Often combined with microneedling for enhanced skin penetration.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 10 mg/ml
Volume to inject: 0.150 ml
Syringe units: 15.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with GHK-Cu (Copper Peptide) defaults. Adjust values as needed.
Side Effects to Monitor
Topical use is generally well-tolerated. May cause temporary skin irritation or redness in sensitive individuals. Injectable use may cause injection site reactions.
Safety Considerations & Risks
Avoid use on broken or infected skin. Some concern about promoting growth of existing skin cancers. Not recommended during pregnancy.